Privacy Policy
Signals Blog

Contributors

Categories

Right Turn: Regenerative medicine debuts on The Late Show

Does it seem like regenerative medicine is having its moment in the sun? Last week, the news that GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) are building a centre for advanced therapeutic cell technologies, with $20 million...

Stem cell community loses a treasured friend

Joe Sornberger is Director of Communications Programs for the Canadian Stem Cell Foundation and author of Dreams & Due Diligence: Till and McCulloch’s Stem Cell Discovery and Legacy. This post is published here with his permission. The stem cell community is...

Cell Therapy Deal Review: November

Welcome to your Cell Therapy Deal Review for the month of November. Astellas failed to achieve the majority share it needed to push through a takeover of Ocata Therapeutics valued at $379 million. ImmunoCellular Therapeutics announced a research agreement with MD...

Right Turn: Making science sexy again

Justin Trudeau, Canada’s “hot” new prime minister, is getting Canadian scientists all worked up – in a good way. For the first time in nearly ten years, the scientific community has a passionate champion in Ottawa ready to undress – sorry unmuzzle – federal scientists...